Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study.

New MRI techniques such as the analysis of magnetization transfer or diffusion have provided evidence for subtle progressive alterations in tissue integrity prior to focal leakage of the blood-brain barrier (BBB) as part of plaque formation in multiple sclerosis. Since inflammation is capable of modulating the microcirculation, we investigated the hypothesis that changes in the local perfusion might be one of the earliest signs of lesion development. 20 patients with definite relapsing-remitting multiple sclerosis were analysed with regard to cerebral blood volume, cerebral blood flow, mean transit time and apparent diffusion coefficient (ADC), as well as conventional MRI parameters, on monthly follow-up scans. Among 89 gadolinium-enhancing lesions, we selected 18 that developed during the study and met strict inclusion criteria. In these, changes of perfusion parameters were detectable not only prior to the BBB breakdown, but also prior to increases in the ADC. Our data indicate that inflammation is accompanied by altered local perfusion, which can be detected prior to permeability of the BBB.

[1]  Dr. David H. Miller The use of MRI in monitoring the treatment of multiple sclerosis , 1996, The Italian Journal of Neurological Sciences.

[2]  Oded Gonen,et al.  Brain metabolite profiles of T1-hypointense lesions in relapsing-remitting multiple sclerosis. , 2003, AJNR. American journal of neuroradiology.

[3]  V. Perry,et al.  TNF-alpha reduces cerebral blood volume and disrupts tissue homeostasis via an endothelin- and TNFR2-dependent pathway. , 2002, Brain : a journal of neurology.

[4]  G. Knudsen,et al.  Cerebral Blood Flow and Oxidative Metabolism during Human Endotoxemia , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  Carlo Pozzilli,et al.  A longitudinal study of MR diffusion changes in normal appearing white matter of patients with early multiple sclerosis. , 2002, Magnetic resonance imaging.

[6]  Ponnada A Narayana,et al.  Magnetic resonance spectroscopy in multiple sclerosis: window into the diseased brain , 2002, Current opinion in neurology.

[7]  F Barkhof,et al.  The role of MRI as a surrogate outcome measure in multiple sclerosis , 2002, Multiple sclerosis.

[8]  L. Steinman,et al.  Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy. , 2002, Annual review of neuroscience.

[9]  J B Poline,et al.  Transient decrease in water diffusion observed in human occipital cortex during visual stimulation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[11]  A. Villringer,et al.  Perfusion and diffusion magnetic resonance imaging in human cerebral venous thrombosis , 2001, Journal of Neurology.

[12]  H. McFarland,et al.  Ring-enhancement in multiple sclerosis: marker of disease severity , 2001, Multiple sclerosis.

[13]  Stephen M. Smith,et al.  A global optimisation method for robust affine registration of brain images , 2001, Medical Image Anal..

[14]  G. Comi,et al.  Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. , 2001, AJNR. American journal of neuroradiology.

[15]  A. Gass,et al.  Acute and chronic changes of the apparent diffusion coefficient in neurological disorders—biophysical mechanisms and possible underlying histopathology , 2001, Journal of the Neurological Sciences.

[16]  M. Décorps,et al.  Methodology of brain perfusion imaging , 2001, Journal of magnetic resonance imaging : JMRI.

[17]  H. McFarland,et al.  Immunopathogenesis of the multiple sclerosis lesion , 2001, Current neurology and neuroscience reports.

[18]  V. Perry,et al.  Interleukin-1β-Induced Changes in Blood–Brain Barrier Permeability, Apparent Diffusion Coefficient, and Cerebral Blood Volume in the Rat Brain: A Magnetic Resonance Study , 2000, The Journal of Neuroscience.

[19]  M Cercignani,et al.  Weekly diffusion-weighted imaging of normal-appearing white matter in MS , 2000, Neurology.

[20]  G J Barker,et al.  The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study. , 2000, Brain : a journal of neurology.

[21]  M Cercignani,et al.  A quantitative study of water diffusion in multiple sclerosis lesions and normal-appearing white matter using echo-planar imaging. , 2000, Archives of neurology.

[22]  A. Ahluwalia,et al.  The Microcirculation and Inflammation: Site of Action for Glucocorticoids , 2000, Microcirculation.

[23]  K. Scheffler,et al.  Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: Application of an extended blood‐brain barrier leakage correction , 2000, Journal of magnetic resonance imaging : JMRI.

[24]  B R Rosen,et al.  Combined diffusion-weighted and perfusion-weighted flow heterogeneity magnetic resonance imaging in acute stroke. , 2000, Stroke.

[25]  G. Comi,et al.  Pathologic damage in MS assessed by diffusion-weighted and magnetization transfer MRI , 2000, Neurology.

[26]  F. Barkhof,et al.  Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability , 1999, Annals of neurology.

[27]  T. Ptak,et al.  Investigation of apparent diffusion coefficient and diffusion tensor anisotrophy in acute and chronic multiple sclerosis lesions. , 1999, AJNR. American journal of neuroradiology.

[28]  S. Reingold,et al.  The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment , 1999, Multiple sclerosis.

[29]  M E Moseley,et al.  MRI abnormalities associated with partial status epilepticus , 1999, Neurology.

[30]  G J Barker,et al.  Serial magnetization transfer imaging to characterize the early evolution of new MS lesions , 1998, Neurology.

[31]  M Filippi,et al.  Magnetization transfer changes in the normal appering white matter precede the appearance of enhancing lesions in patients with multiple sclerosis , 1998, Annals of neurology.

[32]  F. Barkhof,et al.  Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis , 1998, Neurology.

[33]  S. Reingold,et al.  The role of magnetic resonance techniques in understanding and managing multiple sclerosis. , 1998, Brain : a journal of neurology.

[34]  C. Lucchinetti,et al.  Multiple sclerosis: lessons from neuropathology. , 1998, Seminars in neurology.

[35]  M. Symms,et al.  Diffusion changes in status epilepticus , 1997, The Lancet.

[36]  B. Kieseier,et al.  Targets for the therapeutic action of interferon‐β in multiple sclerosis , 1996, Annals of neurology.

[37]  R. Grossman,et al.  Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images. , 1995, AJNR. American journal of neuroradiology.

[38]  J. Kucharczyk,et al.  Diffusion-Weighted Magnetic Resonance Imaging of Acute Focal Cerebral Ischemia: Comparison of Signal Intensity with Changes in Brain Water and Na+,K+ -ATPase Activity , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[39]  J. Warren Nitric oxide and human skin blood flow responses to acetylcholine and ultraviolet light , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  Roland Martin,et al.  Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis , 1992, Annals of neurology.

[41]  R. S. Hinks,et al.  Time course EPI of human brain function during task activation , 1992, Magnetic resonance in medicine.

[42]  B. Rosen,et al.  Functional mapping of the human visual cortex by magnetic resonance imaging. , 1991, Science.

[43]  N. Patronas,et al.  Serial gadolinium‐enhanced magnetic resonance imaging scans in patients with early, relapsing‐remitting multiple sclerosis: Implications for clinical trials and natural history , 1991, Annals of neurology.

[44]  J. Kucharczyk,et al.  Early detection of regional cerebral ischemia in cats: Comparison of diffusion‐ and T2‐weighted MRI and spectroscopy , 1990, Magnetic resonance in medicine.

[45]  S. Hauser,et al.  Substance P immunoreactive astrocytes are present in multiple sclerosis plaques , 1989, Brain Research.

[46]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[47]  B. Siesjö,et al.  Local Cerebral Blood Flow in the Recovery Period following Complete Cerebral Ischemia in the Rat , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[48]  R. Kraus-Ruppert,et al.  The late form of metachromatic leukodystrophy. II. Ultrastructural correlations with morphological and neurochemical findings. , 1972, Journal of the neurological sciences.

[49]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.

[50]  V. Perry,et al.  TNF-a reduces cerebral blood volume and disrupts tissue homeostasis via an endothelin-and TNFR 2-dependent pathway , 2022 .